Engineering novel human sweat gland cell lines using CRISPR/Cas9 and primary cell technologies

被引：0
|
作者：
Wursthorn, A. [1 ]
Sturmheit, T. [2 ]
Pul, U. [1 ]
Kier, J. [2 ]
Brandenburger, M. [2 ]
Ertongur-Fauth, T. [1 ]
机构：
[1] BRAIN AG, Zwingenberg, Germany
[2] Fraunhofer EMB, Lubeck, Germany
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2017年 / 137卷 / 10期
关键词：
D O I：
10.1016/j.jid.2017.07.246
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
248
引用
收藏
页码：S235 / S235
页数：1
相关论文
共 50 条
  • [1] Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9
    Chen, Yuejun
    Cao, Jingyuan
    Xiong, Man
    Petersen, Andrew J.
    Dong, Yi
    Tao, Yunlong
    Huang, Cindy Tzu-Ling
    Du, Zhongwei
    Zhang, Su-Chun
    CELL STEM CELL, 2015, 17 (02) : 233 - 244
  • [2] Engineering of actinomycetes using CRISPR/Cas9 technologies
    Weber, T.
    Tong, Y.
    Blin, K.
    Lee, S. Y.
    PLANTA MEDICA, 2016, 82
  • [3] Protocol for the Generation of Human Pluripotent Reporter Cell Lines Using CRISPR/Cas9
    Zhong, Aaron
    Li, Mu
    Zhou, Ting
    STAR PROTOCOLS, 2020, 1 (02):
  • [4] Genome Engineering of Primary Human B Cells Using CRISPR/Cas9
    Laoharawee, Kanut
    Johnson, Matthew J.
    Lahr, Walker S.
    Peterson, Joseph J.
    Webber, Beau R.
    Moriarity, Branden S.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (165):
  • [5] Mutagenesis and homologous recombination in Drosophila cell lines using CRISPR/Cas9
    Bassett, Andrew R.
    Tibbit, Charlotte
    Ponting, Chris P.
    Liu, Ji-Long
    BIOLOGY OPEN, 2014, 3 (01): : 42 - 49
  • [6] CRISPR/Cas9 advances engineering of microbial cell factories
    Jakociunas, Tadas
    Jensen, Michael K.
    Keasling, Jay D.
    METABOLIC ENGINEERING, 2016, 34 : 44 - 59
  • [7] Genetic engineering using CRISPR/Cas9 as a strategy for the treatment of Sickle Cell Anemia
    Danda Vasconcelos Santos, M.
    Nascimento Ferreira, I.
    Silva Dos Santos, F.
    Silva Souza, K.
    Freire Da Silva, M. R.
    Almeida Candido, M.
    Motteran, F.
    Alexandre De Araujo, L. C.
    Melo De Oliveira, M. B.
    CLINICA CHIMICA ACTA, 2024, 558
  • [8] Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease
    Johnson, Matthew J.
    Laoharawee, Kanut
    Lahr, Walker S.
    Webber, Beau R.
    Moriarity, Branden S.
    SCIENTIFIC REPORTS, 2018, 8
  • [9] Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines
    Ho, Tsui-Ting
    Zhou, Nanjiang
    Huang, Jianguo
    Koirala, Pratirodh
    Xu, Min
    Fung, Roland
    Wu, Fangting
    Mo, Yin-Yuan
    CANCER RESEARCH, 2015, 75
  • [10] Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines
    Ho, Tsui-Ting
    Zhou, Nanjiang
    Huang, Jianguo
    Koirala, Pratirodh
    Xu, Min
    Fung, Roland
    Wu, Fangting
    Mo, Yin-Yuan
    NUCLEIC ACIDS RESEARCH, 2015, 43 (03) : e17
12345